1508TiP The 1920-EORTC-BIORADON study: Molecular characterization of non-small cell lung cancer (NSCLC) and indoor radon exposure in Europe

Authors: Mezquita, L., Turrisi, F., Mauer, M.E., Mallien, C., Xenophontos, E., Olungu, C., Katanga, G., Mota, A-T., Borges, F., Amrane, K., Sullivan, I.G., Rubio-Viqueira, B., Raimbourg, J., Greillier, L., Rogado, J., Rousseau Bussac, G., Aso, S., Morfouace, M., Dingemans, A-M.C., Besse, B.

Source: In Annals of Oncology October 2023 34 Supplement 2:S849-S849

935P A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

Authors: Galot, R., Le Tourneau, C., Licitra, L.F.L., Even, C., Daste, A., Henry, S., Borel, C., Abdeddaim, C., Seront, E., Prevost, J.B., Rutten, A., Saada, E.B., Rolland, F., Livi, L., Specenier, P.M.C., Leys, J., Olungu, C., Fortpied Lefevre, C., Joaquim, A., Machiels, J-P.

Source: In Annals of Oncology October 2023 34 Supplement 2:S588-S589

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.